Entering text into the input field will update the search result below

Kite Pharma Q2 results

Aug. 14, 2014 6:20 PM ETKite Pharma (KITE) StockBy: Douglas W. House, SA News Editor
  • Kite Pharma (NASDAQ:KITE -3.8%) Q2 results: Revenues: $0; Operating Expenses: $11.1M (+677.4%); Net Loss: ($17.4M) (-999%); Loss Per Share: ($2.27) (-609.4%); Quick Assets: $203.4M (+808.0%).
  • No financial guidance given.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
KITE--
Kite Pharma